Reproductive and developmental toxicity assessment of palbociclib, a CDK4/6 inhibitor, in Sprague-Dawley rats and New Zealand White rabbits
Author:
Funder
Pfizer, Inc.
Publisher
Elsevier BV
Subject
Toxicology
Reference32 articles.
1. Palbociclib in hormone-receptor-positive advanced breast cancer;Turner;N. Engl. J. Med.,2015
2. Cyclin D as a therapeutic target in cancer;Musgrove;Nat. Rev. Cancer,2011
3. Requirement for CDK4 kinase function in breast cancer;Yu;Cancer Cell,2006
4. PD0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro;Finn;Breast Cancer Res.,2009
5. Administration, Ibrance Label;U.S.F.a.D,2018
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New approach methodologies to confirm developmental toxicity of pharmaceuticals based on weight of evidence;Reproductive Toxicology;2024-10
2. Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer;Expert Review of Anticancer Therapy;2024-07-09
3. Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature;Cancer Treatment Reviews;2024-07
4. Fertility Preservation for Young Women with Breast Cancer: Review and Perspective;Clinical and Experimental Obstetrics & Gynecology;2024-06-27
5. A novel degradable PCL/PLLA strapping band for internal fixation of fracture;Journal of Materials Science: Materials in Medicine;2023-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3